{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:14:50Z","timestamp":1779333290358,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41391-025-01065-5","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T17:26:26Z","timestamp":1766251586000},"page":"214-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pelvic lymph node dissection in prostate cancer, still no level 1 evidence of oncological benefit. Time to consider surveillance of negative pelvic lymph nodes on PSMA PET scan staging"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-9037","authenticated-orcid":false,"given":"J. W.","family":"Yaxley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"1065_CR1","unstructured":"Lymph node dissection based on 18F-PSMA PET\/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study \u201cPCAN-25-0534RR"},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani GE, Maas M, Nassiri N, Ortega D, Gill K, Dell\u2019Oglio P, et al. Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: A comprehensive systematic review and meta-analysis. Eur Urol Oncol. 2021;4:134\u201349. https:\/\/doi.org\/10.1016\/j.euo.2021.02.001.","journal-title":"Eur Urol Oncol"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/bju.15702","volume":"129","author":"S Carlsson","year":"2022","unstructured":"Carlsson S, Bottai M, Lantz A, Biartell A, Hugosson J, Steineck G, et al. Lymph swelling after radical prostatectomy and pelvic node dissection. BJU Int. 2022;129:695\u201369.","journal-title":"BJU Int"},{"key":"1065_CR4","doi-asserted-by":"publisher","unstructured":"Roberts MJ, Yaxley JW, Stranne J, van Oort IM, Tilki D. Prostate Cancer and Prostatic Diseases; https:\/\/doi.org\/10.1038\/s41391-024-00821-3","DOI":"10.1038\/s41391-024-00821-3"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","volume":"396","author":"CL Vale","year":"2020","unstructured":"Vale CL, Fisher D, Kneebone A, Parker C, Pearse M, Richaud P, et al. ARTISTIC Meta-analysis Group. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet. 2020;396:1422\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(20)31952-8.","journal-title":"Lancet"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2967\/jnumed.119.235029","volume":"61","author":"L Emmett","year":"2020","unstructured":"Emmett L, Tang R, Nandurkar R, Hruby G, Roach P, Watts J, et al. 3-Year freedom from progression after 68Ga-PSMA PET\/CT\u2013triaged management in men with biochemical recurrence after radical prostatectomy: Results of a prospective multicenter trial. J Nucl Med. 2020;61:866\u201372. https:\/\/doi.org\/10.2967\/jnumed.119.235029.","journal-title":"J Nucl Med"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/pros.24884","volume":"85","author":"B Esen","year":"2025","unstructured":"Esen B, Seymen H, Armutlu A, Koseoglu E, Aykanat IC, Zoro\u011flu H, et al. Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET. Prostate. 2025;85:777\u201383. https:\/\/doi.org\/10.1002\/pros.24884.","journal-title":"Prostate"},{"key":"1065_CR8","doi-asserted-by":"publisher","unstructured":"Delclaux L, Ventre KS, Jones D, Lund AW. Trends in Cancer, January, Vol. 2024;10, https:\/\/doi.org\/10.1016\/j.trecan.2023.09.006.","DOI":"10.1016\/j.trecan.2023.09.006"},{"key":"1065_CR9","doi-asserted-by":"publisher","unstructured":"Amiel T, Wurnschimmel C, Heck M, Horn T, Nguyen N, Budaus L, et al. Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study. J Urol. 2021;205:1663\u201370. https:\/\/doi.org\/10.1097\/JU.0000000000001596.","DOI":"10.1097\/JU.0000000000001596"},{"key":"1065_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","volume":"26","author":"P Ost","year":"2025","unstructured":"Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX. Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial. Lancet Oncol. 2025;26:695\u2013706. https:\/\/doi.org\/10.1016\/S1470-2045(25)00197-4.","journal-title":"Lancet Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01065-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01065-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01065-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:41:55Z","timestamp":1779331315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01065-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-01065-5","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A\/Professor Yaxley has no conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}